# Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients

> **NCT06777719** · PHASE1 · RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 9 (estimated)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Eight Treg

## Key facts

- **NCT ID:** NCT06777719
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-03
- **Primary completion:** 2027-05-18
- **Final completion:** 2027-05-18
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06777719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06777719, "Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06777719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*